Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00294476 | IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma | unknown | Phase 2 | 30 | GammaCanINDUSTRY | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00386984 | Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma | completed | Phase 3 | 108 | University Hospital FreiburgOTHER | 1 | Oct 12, 2006 | clinicaltrials |
| Atorvastatin in Myeloma |
| unknown |
| Phase 1 |
| — |
| Bayside HealthOTHER_GOV |
| 1 |
| Oct 11, 2006 |
| clinicaltrials |
| NCT00297557 | Dual Time Point PET Imaging in Lymphoma | unknown | — | — | Royal Marsden NHS Foundation TrustOTHER | 0 | Oct 11, 2006 | clinicaltrials |
| NCT00384553 | Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma | unknown | Phase 1 / Phase 2 | 30 | University of MagdeburgOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00385125 | Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL | unknown | Phase 2 | 30 | University of MagdeburgOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00163930 | Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata | unknown | — | — | Bayside HealthOTHER_GOV | 1 | Oct 3, 2006 | clinicaltrials |
| NCT00383409 | Multivitamins do Not Improve Radiation Therapy Related Fatigue | completed | Phase 2 | 40 | Faculdade de Medicina do ABCOTHER | 1 | Oct 3, 2006 | clinicaltrials |
| NCT00103545 | Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response | completed | Phase 1 / Phase 2 | 36 | AGO Study GroupOTHER | 1 | Oct 2, 2006 | clinicaltrials |
| NCT00382694 | Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients | unknown | Phase 2 | 80 | Nordic Myeloma Study GroupOTHER | 1 | Sep 29, 2006 | clinicaltrials |
| NCT00146276 | Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer | unknown | Phase 3 | 178 | Association of Urologic Oncology (AUO)OTHER | 1 | Sep 27, 2006 | clinicaltrials |
| NCT00333008 | A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status. | unknown | Phase 2 | 27 | The Alvin and Lois Lapidus Cancer InstituteOTHER | 1 | Sep 26, 2006 | clinicaltrials |
| NCT00378755 | Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM | unknown | Phase 2 | 62 | Korean Multiple Myeloma Working PartyOTHER | 1 | Sep 22, 2006 | clinicaltrials |
| NCT00146458 | Usefulness of FDG-PET for Advanced Cervical Cancer | unknown | Phase 3 | 200 | Chang Gung Memorial HospitalOTHER | 1 | Sep 20, 2006 | clinicaltrials |
| NCT00100243 | Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy | completed | Phase 2 | 22 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00103623 | The Plenaxis® Experience Study | suspended | Phase 4 | 2,000 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00291798 | Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane | completed | Phase 2 | 98 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00306553 | Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients | completed | Phase 2 | — | Cytos Biotechnology AGINDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00378222 | Autologous Transplantation for Multiple Myeloma | completed | Phase 3 | 324 | University of BolognaOTHER | 0 | Sep 19, 2006 | clinicaltrials |
| NCT00055432 | Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer | terminated | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Sep 15, 2006 | clinicaltrials |
| NCT00261534 | Cancer Related Fatigue in Patients Receiving Chemotherapy | unknown | — | 90 | Medical Center AlkmaarOTHER | 1 | Sep 14, 2006 | clinicaltrials |
| NCT00194935 | Weekly Topotecan Therapy in Patients With Ovarian Cancer | terminated | Phase 2 | 32 | Weill Medical College of Cornell UniversityOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00220532 | Folate and Protection Against Cervical Cancer | terminated | Phase 1 / Phase 2 | 180 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00272051 | XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy | completed | Phase 3 | 620 | SanofiINDUSTRY | 0 | Sep 13, 2006 | clinicaltrials |
| NCT00375687 | Investigation of Early Hormonotherapy Efficacy of Prostate Cancer | unknown | N/A | 61 | Kaunas University of MedicineOTHER | 1 | Sep 13, 2006 | clinicaltrials |
| NCT00057343 | Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma | terminated | Phase 3 | 400 | BiogenINDUSTRY | 1 | Sep 12, 2006 | clinicaltrials |
| NCT00127088 | Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients | suspended | Phase 2 | 37 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00176761 | Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine | terminated | Phase 2 | 27 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00180830 | Glivec Phase II Pediatric Study | terminated | Phase 2 | 36 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 3 | Sep 11, 2006 | clinicaltrials |
| NCT00180882 | LMBA02 Protocol for Patients With a Burkitt Lymphoma | unknown | Phase 3 | 260 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | terminated | Phase 2 | 40 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 11, 2006 | clinicaltrials |
| NCT00126269 | Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary | unknown | Phase 3 | 192 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00138086 | Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma | completed | Phase 2 | 75 | Lymphoma Study AssociationOTHER | 3 | Sep 8, 2006 | clinicaltrials |
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | unknown | Phase 2 | 210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00311857 | Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) | unknown | Phase 1 / Phase 2 | 46 | Heidelberg UniversityOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00373620 | A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients | unknown | Phase 2 | 50 | Korean Gynecologic Oncology GroupOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00015483 | Hematotoxic Effects of Particulate Exposure | completed | — | — | National Institute of Environmental Health Sciences (NIEHS)NIH | 0 | Sep 4, 2006 | clinicaltrials |
| NCT00015561 | Pesticides--Health Fertility and Reproductive Risk | completed | — | 1,803 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Sep 4, 2006 | clinicaltrials |
| NCT00042445 | Brain Neoplasms, Leukemia and Petrochemical Exposures | completed | — | 1,456 | National Institute of Environmental Health Sciences (NIEHS)NIH | 2 | Sep 4, 2006 | clinicaltrials |
| NCT00101842 | Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer | completed | Phase 1 / Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 29, 2006 | clinicaltrials |
| NCT00300001 | Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes | unknown | — | 300 | Community Cancer CareOTHER | 1 | Aug 25, 2006 | clinicaltrials |
| NCT00231712 | Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant | unknown | — | 50 | Julius-Maximilians UniversityOTHER | 1 | Aug 23, 2006 | clinicaltrials |
| NCT00367185 | Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma | completed | Phase 3 | 500 | University Hospital, LilleOTHER | 1 | Aug 22, 2006 | clinicaltrials |
| NCT00366717 | Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy | completed | — | 20 | Mackay Memorial HospitalOTHER | 1 | Aug 21, 2006 | clinicaltrials |
| NCT00010829 | Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00026975 | Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients | completed | Phase 2 | 150 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00029783 | Efficacy of Distant Healing in Glioblastoma Treatment | completed | Phase 2 | 150 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
| NCT00034970 | Mindfulness-Based Art Therapy for Cancer Patients | completed | N/A | 114 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Oct 12, 2006source: clinicaltrials